摘要 |
Provided are compositions and methods useful for modulation of signalling through the Toll-like receptors TLR7 and/or TLR8. The compositions and methods have use in the treatment of autoinmunity, inflammation allergy, asthma, graft rejection, graft versus host disease, infection, sepsis, cancer and immunodeficiency. |